Correlation
The correlation between MLTX and ^GSPC is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
MLTX vs. ^GSPC
Compare and contrast key facts about MoonLake Immunotherapeutics (MLTX) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MLTX or ^GSPC.
Performance
MLTX vs. ^GSPC - Performance Comparison
Loading data...
Key characteristics
MLTX:
-0.10
^GSPC:
0.66
MLTX:
0.17
^GSPC:
0.94
MLTX:
1.02
^GSPC:
1.14
MLTX:
-0.13
^GSPC:
0.60
MLTX:
-0.34
^GSPC:
2.28
MLTX:
18.86%
^GSPC:
5.01%
MLTX:
50.21%
^GSPC:
19.77%
MLTX:
-64.60%
^GSPC:
-56.78%
MLTX:
-38.91%
^GSPC:
-3.78%
Returns By Period
In the year-to-date period, MLTX achieves a -27.96% return, which is significantly lower than ^GSPC's 0.51% return.
MLTX
-27.96%
-7.82%
-28.33%
-4.06%
71.53%
N/A
N/A
^GSPC
0.51%
3.96%
-2.00%
12.02%
12.68%
14.19%
10.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MLTX vs. ^GSPC — Risk-Adjusted Performance Rank
MLTX
^GSPC
MLTX vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Drawdowns
MLTX vs. ^GSPC - Drawdown Comparison
The maximum MLTX drawdown since its inception was -64.60%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for MLTX and ^GSPC.
Loading data...
Volatility
MLTX vs. ^GSPC - Volatility Comparison
MoonLake Immunotherapeutics (MLTX) has a higher volatility of 15.02% compared to S&P 500 (^GSPC) at 4.77%. This indicates that MLTX's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...